|
|
Identification |
|
Name |
|
Inavolisib |
|
Synonyms |
|
(2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide |
|
|
Molecular Structure |
|
![CAS # 2060571-02-8, Inavolisib, (2S)-2-[[2-[(4S)-4-(difluoromethyl)-2-oxo-1,3-oxazolidin-3-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]amino]propanamide](/structures/2060571-02-8.gif) |
|
|
Molecular Formula |
|
C18H19F2N5O4 |
|
Molecular Weight |
|
407.37 |
|
CAS Registry Number |
|
2060571-02-8 |
|
SMILES |
|
C[C@@H](C(=O)N)NC1=CC2=C(C=C1)C3=NC(=CN3CCO2)N4[C@@H](COC4=O)C(F)F |
| |
|
Properties |
|
|
Density |
|
1.6±0.1 g/cm3, Calc.* |
|
Index of Refraction |
|
1.693, Calc.* |
|
Boiling Point |
|
656.5±65.0 ºC (760 mmHg), Calc.* |
|
Flash Point |
|
350.8±34.3 ºC, Calc.* |
| |
|
|
|
*
|
Calculated using Advanced Chemistry Development (ACD/Labs) Software.
|
|
| |
|
|
|
Safety Data |
|
|
Hazard Symbols |
|
GHS06;GHS08 Danger Details |
|
Hazard Statements |
|
H301-H361 Details |
|
Precautionary Statements |
|
P501-P270-P202-P201-P264-P280-P308+P313-P301+P310+P330-P405 Details |
|
SDS |
|
Available |
| |
|
|
| Market Analysis Reports |
|
|
|
| |
|
|
|
|
